Pharma.com: Academia, Early-Stage Biotech Companies Increasingly Look to CROs to Fill Gap

July 2, 2013

By Zachary Brennan

Academia, Early-Stage Biotech Companies Increasingly Look to CROs to Fill Gaps

Academia and early-stage biotech companies are more frequently looking to fill holes in their expertise and preclinical capacities through the use of CROs, according to a commentary in Nature Reviews Drug Discovery.

http://www.outsourcing-pharma.com/Clinical-Development/Academia-Early-Stage-Biotech-Companies-Increasingly-Look-to-CROs-to-Fill-Gaps